MedTrace Logo

A Clinical Trial of MK-1167 in Healthy Adults (MK-1167-010)

NCT07266818 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-04-28

No results posted yet for this study

Summary

The goal of this trial is to learn about the safety of MK-1167 and if people tolerate it.

Conditions

  • Healthy

Interventions

DRUG

MK-1167

Oral capsule administered once daily

DRUG

Placebo

Oral capsule administered once daily

Sponsors & Collaborators

Principal Investigators

  • Medical Director · Merck Sharp & Dohme LLC

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-18
Primary Completion
2026-04-09
Completion
2026-04-09
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07266818 on ClinicalTrials.gov